Learn how Alzheimer's disease is diagnosed through history, testing, imaging, and emerging blood biomarkers to support early ...

A study suggests that a surprisingly modest daily walking goal could make a difference for your brain as you age.

Could the geometry of our brains increase the risk of Alzheimer’s disease? It’s a provocative question, but one that some ...

Experts discuss the promise and limitations of new tests and treatments for Alzheimer's disease and emerging discoveries on ...

Scientists at Scripps Research have uncovered a molecular “switch” that appears to fuel the damaging brain inflammation seen in Alzheimer’s disease. They found that a protein called STING becomes ...

KARI's multimodal imaging dataset reveals critical insights into Alzheimer's disease, linking amyloid, tau, and brain ...

Agitation associated dementia is one of the most common symptoms of Alzheimer's disease.

The most influential change has been the evolution of biomarkers, beginning around 2012 with the approval of amyloid PET, so ...

The Alzheimer's disease competitive landscape report delivers important insights into approved as well as ongoing research on 240+ pipeline Alzheimer's disease drugs, clinical strategies, upcoming ...

Award to Dr. Walter Swardfager, from Sunnybrook Research Institute, will support a proof-of-mechanism clinical trial ...

In partnership with Eli Lilly and Company, the Suits alum is now raising awareness about early symptomatic Alzheimer's ...

Topline results from the trial are expected in November.